Cognitive reserve protects ALS-typical cognitive domains: A longitudinal study.

Area of Science:

• Neuroscience
• Neurology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
• Cognitive impairment is common in ALS patients, impacting executive functions and memory.
• Cognitive reserve (CR) may mitigate cognitive decline in neurodegenerative diseases.

Purpose of the Study:

• To investigate if cognitive reserve (CR) protects cognitive functions in ALS patients.
• To assess the impact of CR on verbal fluency, executive functioning, and memory over 12 months.
• To determine if CR can predict cognitive decline in amyotrophic lateral sclerosis.

Main Methods:

• A cohort study involving 38 ALS patients (25 without cognitive impairment, 13 with cognitive impairment).
• Cognitive testing (verbal fluency, executive functions, memory) and magnetic resonance imaging (MRI) performed at baseline and 12-month follow-up.
• Brain volume changes in specific regions (superior frontal gyri, orbitofrontal gyri, hippocampi) were analyzed.

Main Results:

• ALS patients experienced significant brain volume loss in frontal regions and hippocampi over 12 months.
• Strong evidence indicates CR protected against decline in letter fluency (Bayes factor >10).
• Moderate evidence suggests CR supported learning in letter flexibility (Bayes factor >3), but not other cognitive domains.

Conclusions:

• Cognitive reserve is a valuable predictive marker in amyotrophic lateral sclerosis.
• CR demonstrates a protective effect on specific cognitive domains, particularly verbal fluency.
• Further research is needed to explore CR's role in other cognitive functions affected by ALS.